TENAX THERAPEUTICS, INC. (TENX) › Operating IncomeTENAX THERAPEUTICS, INC. (TENX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: $10.56M2012: -$8.22M2013: -$5.19M2014: -$16.61M2015: -$14.82M2016: -$52.65M2017: -$9.21M2018: -$6.89M2019: -$8.56M2020: $9.87M2021: -$32.73M2022: $11.05M2023: -$8.23M2024: -$19.49M2025: -$56.38M-$56.38M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$56.38M-189.2%2024-$19.49M-136.8%2023-$8.23M-174.5%2022$11.05M+133.8%2021-$32.73M-431.7%2020$9.87M+215.3%2019-$8.56M-24.1%2018-$6.89M+25.1%2017-$9.21M+82.5%2016-$52.65M-255.3%2015-$14.82M+10.8%2014-$16.61M-220.1%2013-$5.19M+36.9%2012-$8.22M-177.8%2011$10.56M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share